ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS

Código QR

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS

.

Guardado en:

Detalles Bibliográficos
Autores principales:	I. V. Peretokina, L. Yu. Krylova, O. V. Antonova, M. S. Kholina, D. A. Gryadunov, E. Yu. Nosova, D. V. Zimenkov
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/c884e4bf1bcc4e7ca134f230bf138c83
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

MINOR GENETIC DETERMINANTS OF SECOND-LINE INJECTION DRUGS RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
por: R. Jou, et al.
Publicado: (2018)

TB PORTALS PROGRAM: DATA-DRIVEN MULTINATIONAL CONSORTIUM AGAINST DRUG-RESISTANT TUBERCULOSIS
por: A. E. Gabrielian, et al.
Publicado: (2018)

GENOTYPING OF MULTIDRUG AND PREEXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM A HIGH INCIDENCE TB AREA IN MOROCCO
por: I. Chaoui, et al.
Publicado: (2018)

Underutilization of isoniazid drug therapy to prevent TB disease progression in Swaziland
por: B. Cronin, et al.
Publicado: (2015)

GLOBAL WHO POLICIES ON MOLECULAR METHODS FOR TB DIAGNOSIS
por: A. Korobitsyn
Publicado: (2018)

THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS
por: Yu. V. Ostankova
Publicado: (2018)

MOLECULAR-GENETIC METHODS OF DETECTION OF TUBERCULOSIS AND ITS DRUG RESISTANCE IN ARKHANGELSK REGION IN 2017
por: P. I. Eliseev, et al.
Publicado: (2018)

GENOTYPES OF MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM DIFFERENT ORGANS OF PATIENTS WITH GENERALIZED TB AND HIV-COINFECTION
por: A. A. Gerasimova, et al.
Publicado: (2018)

COXIELLA BURNETII PATHOGENICITY MOLECULAR BASIS
por: Yu. A. Panferova
Publicado: (2016)

ANALYSIS OF SECONDARY RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO SECOND-LINE ANTI-TUBERCULOSIS DRUGS IN CASABLANCA
por: G. Momen, et al.
Publicado: (2018)

THE PREVALENCE OF HIV-1 DRUG RESISTANCE MUTATIONS IN PATIENTS WITH LOW ADHERENCE TO ANTIRETROVIRAL THERAPY IN THE LENINGRAD REGION
por: A. N. Shchemelev, et al.
Publicado: (2018)

Molecular Diagnosis of TB in the HIV Positive Population
por: Amy Y. Vittor, et al.
Publicado: (2015)

MOLECULAR-GENETIC BASIS OF PHYSIOLOGY AND PATHOGENICITY OF COXIELLA BURNETII
por: Yu. A. Panpherova
Publicado: (2014)

COULD THE NEW INSIGHTS INTO PZA RESISTANCE PROVIDE ROUTE TO SHORTER MORE EFFECTIVE TB THERAPY?
por: R. M. Anthony
Publicado: (2018)

ANALYSIS OF POPULATIONS OF BACILLUS ANTRACIS STRAINS ON THE BASIS OF THEIR RESISTANCE TO SPECIFIC ANTHRAX BACTERIOPHAGES
por: O. I. Tsygankova, et al.
Publicado: (2018)

Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Shan Zhou, et al.
Publicado: (2021)

What is the TB Burden in Nigerian Prisons? – An Enhanced TB Case Finding Program experience from 13 Nigerian Prisons
por: E. Onu, et al.
Publicado: (2017)

Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
por: Breck A. Duerkop, et al.
Publicado: (2016)

THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY
por: D. E. Valutite, et al.
Publicado: (2018)

EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA
por: M. de Vos, et al.
Publicado: (2018)

Tracing TB: Are there predictors for active TB disease in patients with Xpert Ultra trace results?
por: Wentzel Bruce Dowling, et al.
Publicado: (2022)

POPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM TB-HIV COINFECTED PATIENTS IN OMSK REGION, WEST SIBERIA, RUSSIA
por: O. A. Pasechnik, et al.
Publicado: (2018)

ANTIMICROBIAL ACTIVITY OF SYNTHETIC ANALOGOUS OF CAPRINE PEPTIDES BACTENECINS TOWARDS DRUG-RESISTANT BACTERIA
por: P. M. Kopeykin, et al.
Publicado: (2018)

Immunoglobulins and predicted mortality in clinical course of concomitant HIV and TB infection
por: N. V. Mal’tseva, et al.
Publicado: (2021)

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.
por: Getnet Yimer, et al.
Publicado: (2011)

DETERMINANTS OF TB RELATED DEATH FROM TUBERCULOSIS PATIENTS IN THE NORTHERN THAILAND
por: R. Miyahara, et al.
Publicado: (2018)

Community Members’ Perceptions of Tuberculosis (TB) Stigmatization in Rural Maharashtra, India
por: S. Tilekar, et al.
Publicado: (2017)

COMPARATIVE CHARACTERIZATION OF SUBCULTURES ISOLATED FROM A POPULATION OF BACILLUS ANTHRACIS 1 (SO) STRAIN ON THE BASIS OF PHAGE RESISTANCE TO SOME SPECIFIC ANTHRAX BACTERIOPHAGES
por: O. I. Tsygankova, et al.
Publicado: (2018)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
por: D. E. Valutite, et al.
Publicado: (2018)

HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
por: A. V. Mordyk, et al.
Publicado: (2016)

GENOTYPES OF EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS: CLINICAL AND EPIDEMIOLOGICAL FEATURES OF PULMONARY TUBERCULOSIS
por: N. R. Vasilieva, et al.
Publicado: (2016)

The molecular basis of extensively drug-resistant Salmonella Typhi isolates from pediatric septicemia patients.
por: Chanmi Kim, et al.
Publicado: (2021)

Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
por: Kathiresan Natarajan, et al.
Publicado: (2012)

Teach Back Method: Improving Healthcare Provider Counseling of Pediatric Patients with TB and their Caregivers in Chongqing, China
por: K. Abarcar, et al.
Publicado: (2017)

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN DIFFERENT LOCALIZATIONS OF THE DISEASE
por: P. K. Yablonskii, et al.
Publicado: (2016)

THE PREVALENCE AND MOLECULAR EPIDEMIOLOGY OF STENOTROPHOMONAS MALTOPHILA IN THE INTENSIVE CARE UNITS
por: E. V. Zueva, et al.
Publicado: (2018)

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.
por: Miranda W Langendam, et al.
Publicado: (2013)

GENETIC DIVERSITY AND DRUG RESISTANCE OF MYCOBACTERIUM AVIUM IN ITALY
por: f. Genua, et al.
Publicado: (2018)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Jakub Szymczyk, et al.
Publicado: (2021)

Biological microchip for assessing tetracycline-resistance in <i>Neisseria gonorrhoeae</i> clinical isolates in Russian Federation
por: E. I. Dementieva, et al.
Publicado: (2020)